Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Priorix MMR Vaccine in Healthy Children in Singapore
NCT00388440Phase 4Completed
- Sponsor
- GSK
- Start
- Nov 2000
- Primary completion
- Apr 2001
- Modality
- Vaccines & Immunotherapeutics
01
Overview
Phase 4, open-label, single-arm trial of measles, mumps and rubella vaccine (live) in measles, mumps and rubella, sponsored by GSK. Primary endpoints: Solicited symptoms, Unsolicited Adverse Events and 1 more. Started Nov 2000; status: completed.
02
Drugs
measles, mumps and rubella vaccine (live)
03
Conditions
measlesmumpsrubella
Beyond the preview
Go deeper on NCT00388440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00388440.